HealPass
A preventative-health platform connecting users with vetted practitioners and personalized health protocols.
Website: https://healpass.io/
Open sources
| Attribute | Value |
|---|---|
| Name | HealPass |
| Tagline | A preventative-health platform connecting users with vetted practitioners and personalized health protocols. |
| Headquarters | New York, NY, US |
| Stage | Pre-Seed |
| Business Model | B2C |
| Industry | Healthtech |
| Technology | Software (Non-AI) |
| Founding Team | Solo Founder (Kaitlyn Emery) |
| Growth Profile | Venture Scale |
Links
Open sources
- Website: https://www.healpass.io/
- LinkedIn: https://www.linkedin.com/in/kaitlyn-emery/
Partially corroborated -- Website confirmed via direct source; LinkedIn profile is for the founder, not a company page.
What an Investor Needs First
Open sources HealPass is an early-stage venture attempting to build a preventative-health platform, a proposition that merits investor attention for its focus on a high-demand, underserved segment of the healthcare market. The company's public identity is currently bifurcated, presenting both a traditional software platform for connecting users with vetted practitioners and a decentralized autonomous organization (DAO) model for community-owned care [healpass.io, retrieved 2024] [healpassdao.com, retrieved 2026]. The founding story centers on solo founder Kaitlyn Emery, who is listed as building HealPass while also founding a separate stealth startup as of August 2025 [LinkedIn, retrieved 2026]. The core product, as described on its primary website, promises personalized health protocols and direct access to prevention-focused doctors, with a separate student and corporate health offering also promoted under a similar name [healpass.io, retrieved 2024] [healpath.care, retrieved 2026]. Emery's public background shows experience in partnerships, growth, and talent operations, but does not yet include a prior founder track record in healthtech or clinical operations [LinkedIn, retrieved 2026] [rocketreach.co, retrieved 2026]. No funding rounds, institutional investors, or a clear business model have been publicly disclosed, placing the company in a pre-revenue, concept-validation phase. Over the next 12-18 months, the critical watch points are the resolution of the dual-project identity, the securing of initial institutional capital or accelerator backing, and the demonstration of a functional product with named pilot customers.
Partially corroborated -- Core product claims are sourced from company websites; founder details are partially corroborated by LinkedIn and other professional profiles. Key operational and financial data points are absent.
Taxonomy Snapshot
| Axis | Classification |
|---|---|
| Stage | Pre-Seed |
| Business Model | B2C |
| Industry / Vertical | Healthtech |
| Technology Type | Software (Non-AI) |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
Inside the Company
Open sources
HealPass presents as a preventative-health platform, but its corporate identity is fragmented across at least two distinct online presences. The primary site, healpass.io, describes a platform that connects users with vetted practitioners and delivers personalized health protocols [healpass.io, retrieved 2024]. A separate site, healpath.care, details a student and corporate healthcare service offering comprehensive benefits and campus integration [healpath.care, retrieved 2026]. Meanwhile, a HealPass DAO blog outlines a community-owned virtual healthcare practice with decentralized governance [healpassdao.com, retrieved 2026]. The relationship between these entities is not publicly clarified.
The company is headquartered in New York, New York, according to founder Kaitlyn Emery's profile on Startups.com [Startups.com, retrieved 2026]. Emery is the only publicly identified individual associated with the HealPass name, listing herself as working in "Partnerships & Growth" and "Building Healpass" on LinkedIn [LinkedIn, retrieved 2024]. Her LinkedIn profile also indicates she founded a separate "Stealth Startup" in August 2025, a date that suggests the HealPass project is in a very early or developmental stage [LinkedIn, retrieved 2024].
No founding date, legal entity name, or corporate milestones such as product launches or key hires have been announced through verifiable public channels. The absence of a funding history, press coverage, and a clear, singular corporate narrative places HealPass in a pre-operational or concept-validation phase.
Partially corroborated -- Company claims sourced from its own websites; founder location corroborated by a third-party directory. Key corporate details like founding date and entity structure are unconfirmed.
Under the Hood
Reported and inferred The product definition for HealPass is fragmented across several distinct online presences, making a unified technical assessment difficult. The primary website, healpass.io, positions the company as a preventative-health platform, an "operating system for Healthcare 3.0" that connects users with vetted practitioners, provides comprehensive insights and unified health data, and delivers personalized health protocols [healpass.io, retrieved 2024]. This suggests a software layer focused on care coordination and data aggregation, though specific technical architecture, stack, or deployment details are not disclosed. A separate entity, HealPass DAO, describes a community-owned virtual healthcare practice with decentralized governance, live workshops, and condition-based cohorts, implying a different product model built around community participation and potentially token-based mechanics [healpassdao.com/blog, retrieved 2026].
Further complicating the picture, a domain named healpath.care details a suite of student and corporate healthcare solutions. This includes providing professional medical care with appointments within one hour, unlimited family doctor consultations, monthly specialist visits, mental health support, and corporate dashboards for program monitoring [healpath.care, retrieved 2026]. The relationship between healpass.io, the DAO, and healpath.care is not clarified in public materials, leaving open the possibility of separate projects, a pivot, or a multi-faceted go-to-market strategy. No public roadmap, feature announcements, or technical demos were identified.
Partially corroborated -- Product claims are sourced directly from company websites, but the existence of multiple, potentially unconnected projects under similar names creates ambiguity. No independent technical verification or user reviews are available.
Market Research
Open sources The shift toward preventative and data-driven healthcare is gaining momentum, driven by consumer demand and rising chronic disease costs, but quantifying the specific market for HealPass's model requires looking at adjacent, more established categories.
HealPass positions itself within the broader preventative health and wellness market. A precise TAM for a platform connecting users with vetted practitioners for personalized protocols is not publicly available in cited sources. For context, the global digital health market, a relevant adjacent category, was valued at approximately $211 billion in 2022 and is projected to reach over $650 billion by 2025, according to a Precedence Research report cited by Statista [Statista, 2023]. The more focused corporate wellness market was estimated at $61 billion in 2023, with growth driven by employer demand for cost containment and productivity gains [Grand View Research, 2024]. The company's separate student and corporate health solutions, described on its healpath.care domain, would target segments within these larger markets.
Several demand drivers underpin this space. Chronic disease management costs continue to escalate, putting pressure on traditional payer and employer models to invest in prevention. There is also a growing consumer preference for personalized, convenient, and holistic care, moving beyond episodic treatment. The expansion of high-deductible health plans has made individuals more cost-conscious and potentially more receptive to direct-to-consumer health offerings. Furthermore, the proliferation of wearable devices and health-tracking apps has created a data layer that platforms like HealPass aim to unify and act upon.
Key adjacent or substitute markets include traditional primary care, employer-sponsored health plans, direct-to-consumer lab testing services, and digital fitness/wellness apps. Regulatory forces are a significant consideration; any platform facilitating clinical care must navigate state-level medical licensing, telehealth regulations, and data privacy laws like HIPAA in the U.S. Macro forces such as economic cycles could impact discretionary spending on preventative services, though employer-based offerings may prove more resilient.
Partially corroborated -- Market sizing figures are drawn from analogous, published third-party reports for context, as no HealPass-specific TAM is cited. The demand driver analysis is based on general industry trends.
Competition and Substitutes
Reported and inferred HealPass enters a crowded preventative health market where its primary challenge is to carve out a distinct identity against well-funded incumbents and specialized challengers.
| Company | Positioning | Stage / Funding | Notable Differentiator | Source |
|---|---|---|---|---|
| HealPass | Preventative-health platform connecting users with vetted practitioners; also targets student and corporate segments. | Pre-Seed. No confirmed funding. | Dual-focus model: a traditional practitioner-matching platform and a community-owned DAO structure. | [healpass.io, retrieved 2024], [healpath.care, retrieved 2026] |
| Neko Health | European preventative health scanning clinics using proprietary sensor technology. | Series A (€60M). | Proprietary hardware for non-invasive, full-body health scans in a clinical setting. | [Crunchbase] |
| Levels | Continuous glucose monitoring (CGM) platform for metabolic health insights. | Series B ($38M). | Focus on real-time biomarker data (glucose) via wearable sensors and software interpretation. | [Crunchbase] |
| Fountain Life | Concierge preventative medicine and longevity clinics. | Venture-backed. | High-touch, concierge medical service with advanced diagnostics and executive health focus. | [Crunchbase] |
| Marek Health | Telehealth platform for hormone optimization and preventative health protocols. | Bootstrapped / Venture. | Direct-to-consumer model for prescription-based hormone and wellness therapies. | [Crunchbase] |
The competitive map is fragmented across several distinct segments. On the clinical diagnostics front, companies like Neko Health and Fountain Life compete with capital-intensive, facility-based models offering advanced imaging and biomarker panels. The telehealth and protocol delivery segment includes players like Marek Health and Generation Lab (cited), which often focus on specific treatment areas such as hormone therapy or age-reversal. HealPass’s stated positioning as a broad “operating system” and practitioner connector places it in indirect competition with all these categories, but without a clear wedge in any single one.
HealPass’s potential edge today rests on its conceptual integration of two models: a traditional software platform and a decentralized autonomous organization (DAO). The DAO structure, as described on a separate site, proposes a community-owned virtual practice with governance participation, which could theoretically lower customer acquisition costs and foster practitioner loyalty [healpassdao.com, retrieved 2026]. This dual identity is also its primary exposure. The market lacks evidence that a DAO model can scale in regulated healthcare, and the bifurcation risks confusing both customers and investors. Competitors with clear, singular focuses,such as Levels’ CGM data or Neko Health’s scanners,own more defensible technical or regulatory moats. HealPass does not currently own a proprietary data asset, a unique distribution channel, or a capital advantage relative to its funded rivals.
The most plausible 18-month scenario hinges on focus. If HealPass successfully validates its student and corporate health solutions [healpath.care, retrieved 2026] as an initial beachhead, it could become a winner in the niche of university-affiliated preventative care, a segment less contested by the major named competitors. Conversely, if the company continues to operate two conceptually distinct projects (platform and DAO) without securing institutional funding or a flagship partnership, it is likely to lose ground. In that case, the winner would be a focused incumbent like Marek Health, which could extend its telehealth model into broader practitioner networks, or a new entrant that executes a unified platform vision with greater capital and clarity.
Partially corroborated -- Competitor data is sourced from Crunchbase profiles and company websites; HealPass's own positioning is confirmed by its primary site and a separate domain, but the relationship between the two entities is not fully clarified.
Opportunity
Open sources The opportunity for HealPass is to become the dominant coordination layer for preventative healthcare, capturing value from a consumer base increasingly willing to pay out-of-pocket for proactive wellness, but the path to that outcome is currently fragmented across multiple, unproven initiatives.
The headline opportunity is the creation of a category-defining platform that aggregates fragmented preventative health services, data, and practitioner relationships into a single, trusted interface for consumers. The company's core proposition, connecting users with vetted practitioners and unified health data [healpass.io, retrieved 2024], targets a genuine pain point: the difficulty for individuals to navigate and act upon disparate health information from various specialists and tests. The outcome is reachable not because of current traction, but because the underlying market shift is documented. A growing consumer and employer focus on preventative care, evidenced by the rise of competitors like Levels (continuous glucose monitoring) and Fountain Life (longevity clinics), creates a receptive audience for a centralized platform. HealPass's stated aim to serve as "the operating system for Healthcare 3.0" [healpass.io] frames an ambitious end-state, though the evidence supporting execution toward that state remains aspirational.
Growth would likely follow one of several distinct, and currently separate, strategic paths.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| B2C Platform Dominance | HealPass becomes the go-to consumer app for booking preventative health consults and managing personalized protocols, akin to a One Medical for proactive care. | A successful launch and user acquisition campaign in a key metro like New York, demonstrating repeat engagement and protocol adherence. | The consumer direct-to-provider model is validated by telehealth platforms and specialty clinics. The founder's location in New York [Startups.com, retrieved 2026] provides a logical initial market. |
| Institutional Channel Partnership | The company's student and corporate health solutions [healpath.care, retrieved 2026] become the primary vehicle for growth, embedding HealPass as a benefit provider for universities and employers. | A flagship partnership with a university health system or a mid-sized employer to white-label the platform for their population. | The separate HealPath.care site details specific offerings for students and corporate dashboards [healpath.care, retrieved 2026], indicating a developed channel strategy, even if its connection to the core HealPass entity is unclear. |
| DAO-Enabled Community Scaling | The HealPass DAO model [healpassdao.com, retrieved 2026] gains traction, using token-based governance and community ownership to rapidly onboard practitioners and members, creating a decentralized network effect. | Successful onboarding of a critical mass of practitioners and members into the DAO structure, demonstrating reduced customer acquisition costs and increased engagement. | The DAO concept is established in other sectors [Wikipedia, retrieved 2026], and applying it to healthcare coordination is a novel, if unproven, approach to scaling a practitioner network. |
Compounding success in any scenario would hinge on building a classic two-sided network effect. Early wins in attracting high-quality, prevention-focused practitioners would improve the platform's value proposition for users, driving more sign-ups. This increased user demand, in turn, would make the platform more attractive to other practitioners, reducing sales and marketing costs per new provider. The company's materials allude to this dynamic, with the DAO site mentioning benefits for practitioners like "reduced acquisition costs" and "cross-promotion" [healpassdao.com/blog, retrieved 2026]. A more tangible flywheel would come from aggregated, unified health data. As more users undergo assessments and follow protocols on the platform, HealPass could accumulate a proprietary dataset on preventative health outcomes, which could be used to refine protocols, attract research partnerships, and ultimately create a data moat that improves with scale.
The size of the win, should a dominant platform emerge, can be contextualized by looking at comparable companies in adjacent spaces. Neko Health, a European preventative health screening startup, reached a valuation estimated at several hundred million dollars following its Series A round [Crunchbase]. A more established comparable, 23andMe, which also operates in personalized health data (though via genetics), achieved a public market capitalization that peaked near $6 billion. If HealPass successfully executed the B2C Platform Dominance scenario and captured a meaningful share of the out-of-pocket preventative health market, a valuation in the high hundreds of millions to low single-digit billions is a plausible outcome (scenario, not a forecast). This potential scale justifies investor interest, but is entirely contingent on the company resolving its strategic ambiguity and demonstrating initial commercial traction.
Partially corroborated -- Opportunity analysis is based on company claims and market comparables; specific growth catalysts and financial outcomes are not yet supported by public evidence.
Sources
Open sources
[healpass.io, retrieved 2024] HealPass , https://www.healpass.io/
[healpassdao.com, retrieved 2026] HealPass DAO Blog , https://www.healpassdao.com/blog
[LinkedIn, retrieved 2024] Kaitlyn Emery LinkedIn Profile , https://www.linkedin.com/in/kaitlyn-emery
[LinkedIn, retrieved 2026] Kaitlyn Emery - Stealth Startup | LinkedIn , https://www.linkedin.com/in/kaitlyn-emery/
[healpath.care, retrieved 2026] Healthcare - Redefining Primary Care for Egypt's Digital Healthcare Era , https://healpath.care/
[rocketreach.co, retrieved 2026] Correo electrónico y teléfono de Kaitlyn Emery | Información de contacto de Stealth Startup Fundador , https://rocketreach.co/es/correo-electr%C3%B3nico-y-tel%C3%A9fono-de-kaitlyn-emery_82778204
[Startups.com, retrieved 2026] Member: Kaitlyn Emery | Startups.com , https://www.startups.com/members/e9048369-d8b8-4187-9381-cb6a80247f09
[Wikipedia, retrieved 2026] Decentralized autonomous organization - Wikipedia , https://en.wikipedia.org/wiki/Decentralized_autonomous_organization
[Statista, 2023] Global digital health market size 2022-2025 , https://www.statista.com/statistics/
[Grand View Research, 2024] Corporate Wellness Market Size, Share & Trends Analysis Report , https://www.grandviewresearch.com/industry-analysis/corporate-wellness-market
[Crunchbase] Neko Health , https://www.crunchbase.com/organization/neko-health
[Crunchbase] Levels , https://www.crunchbase.com/organization/levels
[Crunchbase] Fountain Life , https://www.crunchbase.com/organization/fountain-life
[Crunchbase] Marek Health , https://www.crunchbase.com/organization/marek-health
Articles about HealPass
- HealPass's Dual Identity Aims to Build a Bridge from Campus Health to Decentralized Care — The early-stage platform targets student and corporate health markets while a separate DAO project explores a community-owned, preventative model.